TY - JOUR
T1 - Optimal number of days for home blood pressure measurement
AU - Niiranen, Teemu J.
AU - Asayama, Kei
AU - Thijs, Lutgarde
AU - Johansson, Jouni K.
AU - Hara, Azusa
AU - Hozawa, Atsushi
AU - Tsuji, Ichiro
AU - Ohkubo, Takayoshi
AU - Jula, Antti M.
AU - Imai, Yutaka
AU - Staessen, Jan A.
N1 - Funding Information:
This work was supported by The European Union (grants IC15-CT98-0329-EPOGH, LSHM-CT-2006–037093 InGenious HyperCare, HEALTH-F4-2007–201550 HyperGenes, HEALTH-F7-2011-278249 EU-MASCARA, HEALTH-F7-305507 HOMAGE, and the European Research Council Advanced Research Grant 294713 EPLORE) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0734.09, G.0881.13, and G.0880.13N) supported the Studies Coordinating Centre (Leuven, Belgium). The Ohasama study was supported by the Grants for Scientific Research (23249036, 23390171, 24591060, 24390084,
Funding Information:
24591060, 22590767, 22790556, 23790718, 23790242, and 24790654) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Health Labour Sciences Research Grant (H23-Junkankitou [Seishuu]-Ippan-005) from the Ministry of Health, Labour and Welfare, Japan; the Japan Arteriosclerosis Prevention Fund; and the grant from the Daiwa Securities Health Foundation. The Finn-Home project organization created for the study involved the Finnish Centre for Pensions, the Social Insurance Institution, the National Public Health Institute, the Local Government Pensions Institution, the National Research and Development Centre for Welfare and Health, the Finnish Dental Society and the Finnish Dental Association, Statistics Finland, the Finnish Institute for Occupational Health, the UKK Institute for Health Promotion, the State Pensions Office, and the State Work Environment Fund. The Tsurugaya study was supported by a Health Sciences Research Grant for Health Service (H21-Choju-Ippan-001) from the Ministry of Health, Labour, and Welfare, Japan, and the Japan Arteriosclerosis Prevention Fund.
Publisher Copyright:
© American Journal of Hypertension, Ltd 2014. All rights reserved.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Background Current guidelines make no outcome-based recommendations on the optimal measurement schedule for home blood pressure (BP). METHODS We enrolled 4,802 randomly recruited participants from three populations. The participants were classified by their (i) cross-classification according to office and home BP (normotension, masked hypertension, white-coat hypertension, and sustained hypertension) and (ii) home BP level (normal BP, high normal BP, grade 1 and 2 hypertension), while the number of home measurement days was increased from 1 to 7. The prognostic accuracy of home BP with an increasing number of home BP measurement days was also assessed by multivariable-adjusted Cox models. RESULTS Agreement in classification between consecutive measurement days indicated near perfect agreement (κ ≥ 0.9) after the sixth measurement day for both office and home BP cross-classification (97.8% maintained classification, κ = 0.97) and home BP level (93.6% maintained classification, κ = 0.91). Over a follow-up of 8.3 years, 568 participants experienced a cardiovascular event, and the first home BP measurement alone predicted events significantly (P ≤ 0.003). The confidence intervals (CIs) were too wide and overlapping to show superiority of multiple measurement days over the first measurement day (hazard ratios per 10 mm Hg increase in systolic BP at initial day, 1.11 [CI 1.07-1.16]; that at 1-7 days, 1.18 [CI 1.12-1.24]). Masked hypertension, but not white-coat hypertension, was associated with increased cardiovascular risk, irrespective of the number of home measurement days. CONC LUSION Even a single home BP measurement is a potent predictor of cardiovascular events, whereas seven home measurement days may be needed to reliably diagnose hypertension.
AB - Background Current guidelines make no outcome-based recommendations on the optimal measurement schedule for home blood pressure (BP). METHODS We enrolled 4,802 randomly recruited participants from three populations. The participants were classified by their (i) cross-classification according to office and home BP (normotension, masked hypertension, white-coat hypertension, and sustained hypertension) and (ii) home BP level (normal BP, high normal BP, grade 1 and 2 hypertension), while the number of home measurement days was increased from 1 to 7. The prognostic accuracy of home BP with an increasing number of home BP measurement days was also assessed by multivariable-adjusted Cox models. RESULTS Agreement in classification between consecutive measurement days indicated near perfect agreement (κ ≥ 0.9) after the sixth measurement day for both office and home BP cross-classification (97.8% maintained classification, κ = 0.97) and home BP level (93.6% maintained classification, κ = 0.91). Over a follow-up of 8.3 years, 568 participants experienced a cardiovascular event, and the first home BP measurement alone predicted events significantly (P ≤ 0.003). The confidence intervals (CIs) were too wide and overlapping to show superiority of multiple measurement days over the first measurement day (hazard ratios per 10 mm Hg increase in systolic BP at initial day, 1.11 [CI 1.07-1.16]; that at 1-7 days, 1.18 [CI 1.12-1.24]). Masked hypertension, but not white-coat hypertension, was associated with increased cardiovascular risk, irrespective of the number of home measurement days. CONC LUSION Even a single home BP measurement is a potent predictor of cardiovascular events, whereas seven home measurement days may be needed to reliably diagnose hypertension.
KW - Blood pressure
KW - Cardiovascular diseases
KW - Home blood pressure monitoring
KW - Hypertension
KW - Meta-analysis
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=84941557757&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941557757&partnerID=8YFLogxK
U2 - 10.1093/ajh/hpu216
DO - 10.1093/ajh/hpu216
M3 - Article
C2 - 25399016
AN - SCOPUS:84941557757
SN - 0895-7061
VL - 28
SP - 595
EP - 603
JO - American Journal of Hypertension
JF - American Journal of Hypertension
IS - 5
ER -